Sorafenib Capsules IP
Generic name: Sorafendr
Product name: Sorafenib Capsules IP
Preparation: Capsule
Specification: 200mg/120
Product
Sorafenib (co-developed and co-marketed by INDAR as Sorafendr, is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
